JPS61242585A - Production of gamma-halogenated-beta-hydroxybutyric acid - Google Patents
Production of gamma-halogenated-beta-hydroxybutyric acidInfo
- Publication number
- JPS61242585A JPS61242585A JP8454885A JP8454885A JPS61242585A JP S61242585 A JPS61242585 A JP S61242585A JP 8454885 A JP8454885 A JP 8454885A JP 8454885 A JP8454885 A JP 8454885A JP S61242585 A JPS61242585 A JP S61242585A
- Authority
- JP
- Japan
- Prior art keywords
- halogenated
- gamma
- genus
- crotonic acid
- hydroxybutyric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、光学活性なγーハロゲン化ーβーヒドロキシ
酪酸の製法に関する。更に詳しくは、γ一ハロゲン化ク
ロトン酸を、光学活性なγーハロゲン化ーβーヒドロキ
シ酪酸に変換せしめる能力を有する微生物を水性媒体中
で、作用させる事を特徴とする光学活性なγーハロゲン
化ーβーヒドロキシ酪酸の製法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing optically active γ-halogenated-β-hydroxybutyric acid. More specifically, optically active γ-halogenated β-β is produced by treating microorganisms capable of converting γ-halogenated crotonic acid into optically active γ-halogenated β-hydroxybutyric acid in an aqueous medium. - Concerning the production method of hydroxybutyric acid.
γーハロゲン化ーβーヒドロキシ酪酸は、光学活性を有
する種々の天然物、または医薬品などの生理活性物質を
合成する際に有用な中間原料である。例えば、健胃消化
剤としてよく知られているL一カルニチンハ、γーハロ
ゲン化ーβーヒドロキシ酪酸に過剰のトリメチルアミン
を反応させることにより容易に得られる。γ-halogenated β-hydroxybutyric acid is a useful intermediate raw material in the synthesis of various optically active natural products or physiologically active substances such as pharmaceuticals. For example, it can be easily obtained by reacting L-carnitine, γ-halogenated-β-hydroxybutyric acid, which is well known as a stomachic digestive agent, with excess trimethylamine.
(従来の技術)
L一カルニチンの合成法としては、特開昭57−397
91号、特開昭59−192095号が知られている。(Prior art) As a method for synthesizing L-carnitine, Japanese Patent Application Laid-Open No. 57-397
No. 91 and JP-A-59-192095 are known.
特開昭57−39791号には、基質であるγープチロ
ベタインの他に、2−オキソグルタミン酸ナトリウム、
還元剤および第一鉄イオン源を水酸基供与性溶媒に溶か
した溶液をニー−ロスボラ・クラップの胞子より放出さ
れる物質からなる相に接触せしめる事を特徴とするL一
カルニチンの合成方法− を示しており、特開昭59−
1 92095号には、クロトンベタインをL一カルニ
チンに変換せしめる能力を有する微生物の作用によりL
一カルニチンを合成する方法を示している。JP-A No. 57-39791 discloses that in addition to the substrate γ-butirobetaine, sodium 2-oxoglutamate,
A method for synthesizing L-carnitine characterized in that a solution of a reducing agent and a ferrous ion source dissolved in a hydroxyl-donating solvent is brought into contact with a phase consisting of a substance released from spores of N. rosbora crap. Published in Japanese Unexamined Patent Publication No. 59-
No. 192095 discloses that L-carnitine is converted into L-carnitine by the action of microorganisms that have the ability to convert crotonbetaine into L-carnitine.
A method for synthesizing monocarnitine is shown.
(発明が解決しようとする問題点)
しかしながら特開昭57−39791号においては、反
応系が複雑である事、及び収率が低い等の問題がある。(Problems to be Solved by the Invention) However, JP-A-57-39791 has problems such as a complicated reaction system and a low yield.
また特開昭59−192095号においても、収率が低
い等の問題がある。即ち未だ満足すベキL−カルニチン
の合成法がないのが実情である。Furthermore, JP-A-59-192095 also has problems such as low yield. That is, the reality is that there is still no satisfactory method for synthesizing L-carnitine.
(問題点を解決するための手段)
本発明者等は、以上の様な情勢下種々検討した結果、L
−カルニチンに容易に変換される中間体の優れた製法を
見い出し本発明を完成させるに至った。即ちγ−ハロゲ
ン化クロトン酸を光学活性なγ−ハロゲン化−β−ヒド
ロキシ酪酸に変換せしめるに際し、γ−ハロゲン化クロ
トン酸を光学活性なγ−ハロゲン化−β−ヒドロキシ酪
酸に変換せしめる能力を有する微生物を水性媒体中で作
用させる事を特徴とする光学活性なγ−ハロゲン化−β
−ヒドロキシ酪酸の製法が提供される。(Means for solving the problem) As a result of various studies under the circumstances described above, the inventors of the present invention found that L.
-We have discovered an excellent method for producing an intermediate that is easily converted to carnitine, and have completed the present invention. That is, when converting γ-halogenated crotonic acid to optically active γ-halogenated β-hydroxybutyric acid, it has the ability to convert γ-halogenated crotonic acid to optically active γ-halogenated β-hydroxybutyric acid. Optically active γ-halogenated-β characterized by allowing microorganisms to act in an aqueous medium
- A method for producing hydroxybutyric acid is provided.
以下、本発明を更に詳細に説明する。The present invention will be explained in more detail below.
γ−ハロゲン化クロトン酸を光学活性なγ−ハロゲン化
−β−ヒドロキシ酪酸に変換せしめるに際し、γ−ハロ
ゲン化クロトン酸を光学活性なγ−ハロゲン化−β−ヒ
ドロキシ酪酸に変換せしめる能力を有する微生物を水性
媒体中で作用させる方法ハ、水性媒体中にて、γ−ハロ
ゲン化クロトン酸と、上記微生物の菌体、培養液あるい
は、菌体処理物とを接触せしめればよい。A microorganism having the ability to convert γ-halogenated crotonic acid to optically active γ-halogenated β-hydroxybutyric acid when converting γ-halogenated crotonic acid to optically active γ-halogenated β-hydroxybutyric acid. A method for causing γ-halogenated crotonic acid to act in an aqueous medium is to bring the γ-halogenated crotonic acid into contact with the cells, culture solution, or treated product of the microorganism.
本発明において用いられるγ−710ゲン化クロトン酸
を光学活性なγ−ハロゲン化−β−ヒドロキシ酪酸に変
換せしめる能力を有する微生物としては、例えば、アル
カリゲネス(Alcaligenes )属、ブレラ(
Bullera )属、アシネトノくフタ−(Ac1n
etobacter )属、クリプトコツカス(cry
ptococcus )属、キャンデイダ(Candi
da )属、デバリオマイセス(、Debaryomy
ces )属、クレノケラ(Kloeckera J属
、ハンゼニアスポラ(Hanseniaspora )
属、アグロノくクテリウム(Agrobacteriu
m )属、パキゾーレン(Pachy−solen )
属、アルスロバクタ−(Arthrobacter)属
、ピキア(Pichia )属、ノカルディア(Noc
−3rdia )属、プロタミノノ(フタ−(Prot
amin−obacter )属、リポマイセス(Li
pomyces )属、ロドトルラ(Rhodotor
ula J属、ロドスポリデイウム(phodospo
ridium )属、サッカoマイセス(Saccha
romyces )属、キサントモナス(xantho
monas )属、ビブリオ(Vibrio )属、ア
クロモバクタ−(Achromobacter J属、
エルビニア(Erwinia )属、バチルス(Bac
illus )属、ブレビバクテリウム(Brevib
acterium )属、コリネバクテリウム(Oor
ynebacterium )属、シソサノカロマイセ
、x、 (schizosaccharom−yces
)属、クロエソケラ(xloeckera )属、ト
ルロプシス(Torulopsis )属、シュードモ
ナス(Pseudomonas )属、ミクロコツカス
(Mic−rococcus )属、チオノ(チルス(
Th1obacillus)属、トリコスポo ン(T
richosporon )属、プロテウス(Prot
eus )属、ストレプトマイセス(Streptom
yces )属、セラチア(5erratia )属、
サルモネラ(Salmonel Ia )属、ノ1ンゼ
ヌラ(Hansenula )属、 スポリデイオボル
ス(5po−ridiol〕olus )属、エツシエ
リヒア(Escheri−chia )属、エンテロバ
クタ−(Enterobacter )属、エンドマイ
セス(Endomyces )属、クルイベロミセス(
Kluyveromyces )属、へりコステイルム
(Hel icostylum )属、トレメラ(Tr
em−ella)属、ジオトリクム(Geotrich
um )属、デバリオマイセス(Debaryomyc
es )属、ミクロバクテリウム(Microbact
erium )属、クルチア(Kuribia )属、
エアロモナス(Aeromonas )属、アゾトバク
タ−(Azoiobacter )属、スタフィロコッ
カス(5taphy’1ococcus)属等があげら
れる。Examples of microorganisms having the ability to convert γ-710-genated crotonic acid to optically active γ-halogenated-β-hydroxybutyric acid used in the present invention include Alcaligenes genus, Brera (
Bullera) genus, Acinetonokuta (Ac1n)
Etobacter ) genus, Cryptococcus (cry
ptococcus) genus, Candi
da), Debaryomyces (, Debaryomyces
ces), Kloeckera J, Hanseniaspora
Genus, Agrobacterium
m) genus, Pachy-solen
Genus, Arthrobacter, Pichia, Nocardia
-3rdia) genus, Protaminono (Prot.
amin-obacter) genus, Lipomyces (Li
Pomyces) genus, Rhodotorula
Genus ula J, Rhodosporidium (phodospo
ridium) genus, Saccha omyces (Saccha
romyces), xanthomonas (xanthomonas)
monas ) genus, Vibrio genus, Achromobacter (Achromobacter J genus,
Genus Erwinia, Bacillus
illus), Brevibacterium (Brevib
acterium ) genus, Corynebacterium (Oor
ynebacterium), Schizosaccharomyces x, (schizosaccharom-yces)
), xloeckera , Torulopsis , Pseudomonas , Micrococcus , Chiono (
Th1obacillus) genus, Trichospoon (T
richosporon), Proteus (Prot.
eus) genus, Streptomyces (Streptomyces)
yces) genus, Serratia (5erratia) genus,
Salmonella genus, Hansenula genus, Sporidiobolus genus, Escheri-chia genus, Enterobacter genus, Endomyces genus myces) genus, Kluyveromyces (
Kluyveromyces), Helicostylum, Tremella (Tr)
em-ella), Geotrich
um ) genus, Debaryomyces
es ) genus, Microbacterium (Microbacterium
erium) genus, Kuribia genus,
Examples include the genus Aeromonas, the genus Azoobacter, and the genus Staphylococcus.
これらの微生物の菌体を得るには、通常の培地を用いて
、培養の初めから、あるいは培養の途中でγ−・・ロゲ
ン化クロトン酸を添加して培養すればよい。本微生物を
培養するために用いられる培地は、天然培地、半合成培
地、合成培地等いずれも使用する事ができる。即ち、γ
−ハロゲン化り機酸、アルコール類等の炭素源、ペプト
ン、肉エキス、酵母エキス、乾燥酵母、大豆粕、尿素、
チオ尿素、アンモニウム塩、硝酸塩、その他有機あるい
は無機窒素化合物等の窒素源、マグネシウム、マンガン
、カリウム、カルシウム、鉄等のリン酸塩、硝酸塩、炭
酸塩、塩化物等の無機塩が用いられる。またアミノ酸類
、ビタミン類、核酸およびその関連化合物を添加しても
よい。In order to obtain cells of these microorganisms, it is sufficient to culture them using a normal medium and adding γ-...rogenated crotonic acid from the beginning of the culture or during the culture. The medium used for culturing this microorganism can be any of natural medium, semi-synthetic medium, synthetic medium, etc. That is, γ
- Halogenated organic acids, carbon sources such as alcohols, peptone, meat extract, yeast extract, dried yeast, soybean meal, urea,
Nitrogen sources such as thiourea, ammonium salts, nitrates, and other organic or inorganic nitrogen compounds, and inorganic salts such as phosphates, nitrates, carbonates, and chlorides of magnesium, manganese, potassium, calcium, iron, etc., are used. Also, amino acids, vitamins, nucleic acids and related compounds may be added.
培養は通常の好気的培養法に準するが、たとえば培養液
のpHは4〜8が好適であり培養温度は20〜50℃が
好適である。又培養期間は12時間〜10日で好適に培
養できる。Cultivation is carried out in accordance with the usual aerobic culture method, and for example, the pH of the culture solution is preferably 4 to 8, and the culture temperature is preferably 20 to 50°C. Moreover, the culture can be suitably carried out for a period of 12 hours to 10 days.
以上のようにして得られた菌体を用いγ−ハロゲン化ク
ロトン酸に作用させる方法としては、上記に示した方法
で培養しなからγ−ハロゲン化クロトン酸を、培養の初
めから、あるいは培養の途中で添加し作用させる方法、
又は、培養終了後の培養液その1寸、又は培養液より通
常当該分野で用いられる方法により分離した菌体、又は
洗浄した菌体、又は菌体処理物、例えば凍結乾燥菌体、
アセトン乾燥菌体、トルエン、界面活性剤等と接触せし
めた菌体、リゾチームで処理した菌体、超音波処理した
菌体、機械的に摩砕した菌体等の他、これら菌体処理物
から得られたγ−ハロゲン化クロトン酸を光学活性なγ
−ハロゲン化−β−ヒドロキシ酪酸に変換せしめる酵素
活性を有する酵素蛋白部分、更には、これらの菌体、酵
素の固定化物、菌体処理物の不溶化物等と、γ−ハロゲ
ン化クロトン酸を溶解又はけん濁した水性媒体を10℃
〜80℃の温度に調節し、pHを4〜8に保ちつつ、攪
拌又は静置すればよい。このようにして5〜200時間
経過させ、水性媒体中に光学活性なγ−ハロゲン化−β
−ヒドロキシ酪酸を生成、蓄積させる方法が用いられる
。使用する水性媒体としては、水、緩衝液、エタノール
等の有機溶媒を含むもの、例えば、リン酸塩、炭酸塩、
酢酸塩、酒石酸塩、乳酸塩、ホウ酸塩、マレイン酸塩、
クエン酸塩、コハク酸塩、重フタル酸塩、トリス等の緩
衝液又は、水と混和しつる有機溶媒、例えばメタノール
、エタノール、プロパツール、プロピレングリコール等
のアルコール類、酢酸メチル等のエステル類、アセトン
等のケトン類、アセトアミド等のアミド類等が代表的な
例であるが、以上のものが使用できる。The method of using the bacterial cells obtained as described above to act on γ-halogenated crotonic acid is to culture them using the method shown above and then apply γ-halogenated crotonic acid from the beginning of the culture, or How to add and make it work in the middle of
Alternatively, one inch of the culture fluid after completion of culture, or bacterial cells isolated from the culture fluid by a method commonly used in the field, or washed bacterial cells, or a processed product of bacterial cells, such as freeze-dried bacterial cells,
In addition to acetone-dried bacterial cells, bacterial cells that have been brought into contact with toluene, surfactants, etc., bacterial cells that have been treated with lysozyme, bacterial cells that have been treated with ultrasound, mechanically ground bacterial cells, and other bacterial cells that have been treated with these bacterial cells, The obtained γ-halogenated crotonic acid is converted into an optically active γ
- Dissolve γ-halogenated crotonic acid with the enzyme protein portion having the enzymatic activity to convert it into halogenated β-hydroxybutyric acid, as well as these bacterial cells, immobilized enzymes, insolubilized products of bacterial cell processing, etc. Or suspend the aqueous medium at 10°C.
What is necessary is just to stir or stand still while adjusting the temperature to ~80 degreeC and keeping pH at 4-8. After 5 to 200 hours in this manner, optically active γ-halogenated-β was added to the aqueous medium.
- A method for producing and accumulating hydroxybutyric acid is used. The aqueous medium used includes water, buffer solutions, organic solvents such as ethanol, etc., such as phosphates, carbonates,
acetate, tartrate, lactate, borate, maleate,
Buffers such as citrate, succinate, biphthalate, Tris, etc., or organic solvents miscible with water, alcohols such as methanol, ethanol, propatool, propylene glycol, esters such as methyl acetate, Typical examples include ketones such as acetone, amides such as acetamide, and the above can be used.
更に必要に応じて、微生物の生育に必要な栄養源、又は
抗酸化剤、又は界面活性剤、又は補酵素、又はヒドロキ
シルアミン、又は金属イオン等を水性媒体中に添加する
ことも可能である。Furthermore, if necessary, nutrients, antioxidants, surfactants, coenzymes, hydroxylamine, metal ions, etc. necessary for the growth of microorganisms can be added to the aqueous medium.
このようにして得られたl光学活性なγ−ハロゲン化−
β−ヒドロキシ酪酸は、通常よく知られた方法で光学活
性を有する種々の天然物、又は医薬品などの生理活性物
質に容易に変換される。例えば過剰のトリメチルアミン
との反応によりL−カルニチンが容易に合成でき又、過
剰のアンモニアとの反応により医薬品として使用されて
いるL−γ−アミンーβ−ヒドロキシ酪酸が容易に合成
・ できる。The thus obtained optically active γ-halogenated
β-Hydroxybutyric acid is easily converted into various optically active natural products or physiologically active substances such as pharmaceuticals by well-known methods. For example, L-carnitine can be easily synthesized by reaction with excess trimethylamine, and L-γ-amine-β-hydroxybutyric acid, which is used as a pharmaceutical, can be easily synthesized by reaction with excess ammonia.
(発明の効果)
以上に示したように、本発明は、光学活性を有する種々
の天然物、又は医薬品などの生理活性物質を合成する際
に有用な中間原料の効率的な合成法であり、産業上極め
て有用である。(Effects of the Invention) As shown above, the present invention is an efficient method for synthesizing intermediate raw materials useful in synthesizing various optically active natural products or physiologically active substances such as pharmaceuticals. It is extremely useful in industry.
以下実施例を用いて本発明を更に詳細に説明する。The present invention will be explained in more detail below using Examples.
実施例1
グリセリン10グ/11アスパラギン27/l、K2H
P0.1 y / 1XFeSO,・7H200,1f
f/ l。Example 1 Glycerin 10g/11 Asparagine 27/l, K2H
P0.1y/1XFeSO, 7H200, 1f
f/l.
MnCt2*4H,,00,1y/LXZn+sO,・
7H3O[]、1 ff7t、酵母エキス27/l、ペ
プトン2f!/L及びγ−クロロクロトン酸31iI/
l (pn7.o )を500m1容量の振とりフラス
コに100Wl/!入れ120℃で15分殺菌した後、
あらかじめブイヨン培地で60℃、12時間前培養した
第1表に示す微生物を接種し、60℃で、24時間振と
り培養した。MnCt2*4H,,00,1y/LXZn+sO,・
7H3O[], 1 ff7t, yeast extract 27/l, peptone 2f! /L and γ-chlorocrotonic acid 31iI/
l (pn7.o) into a 500ml shaker flask at 100Wl/! After sterilizing at 120℃ for 15 minutes,
The microorganisms shown in Table 1 which had been precultured in a broth medium at 60°C for 12 hours were inoculated, and cultured with shaking at 60°C for 24 hours.
この培養液より菌体を遠心分離により採取し、培養液と
同様の生理的食塩水で一回洗浄し、菌体を集めた。この
菌体とγ−クロロクロトン酸502/lを含む0.5
Mリン酸緩衝液(pH7,0) 100尻lに添加し6
0℃で10時間反応した。Bacterial cells were collected from this culture solution by centrifugation, washed once with the same physiological saline as the culture solution, and collected. 0.5 containing this bacterial body and 502/l of γ-chlorocrotonic acid
Add to 100 liters of M phosphate buffer (pH 7.0) and add 6
The reaction was carried out at 0°C for 10 hours.
反応後の液を遠心分離により菌体を取り除いた後、反応
生成物をガスクロマトグラフィーマススペクトロメトリ
ー、NMR1■R1元素分析で同定したところβ−ヒド
ロキシ−γ−クロロ酪酸である事が判った。この液に6
0%トリメチルアミンを10m1入れ、80℃で5時間
還流しながら攪拌した後、過剰のトリメチルアミンを減
圧下に留去した。このようにして得られた反応物をデビ
ット、ジエイ、ビスアンらの方法で分析した(Met−
hod of Enzymatic Analysis
、第4巻く第2版>、 1974年、 1758 、
Academic press参照)ところ第1表に
示したようにL−カルニチンが検出された。After removing the bacterial cells from the reaction solution by centrifugation, the reaction product was identified by gas chromatography mass spectrometry and NMR1/R1 elemental analysis, and was found to be β-hydroxy-γ-chlorobutyric acid. 6 in this liquid
10 ml of 0% trimethylamine was added, and the mixture was stirred under reflux at 80° C. for 5 hours, and then excess trimethylamine was distilled off under reduced pressure. The reaction product thus obtained was analyzed by the method of David, Jie, Bisian et al. (Met-
hod of enzymatic analysis
, Volume 4, 2nd edition>, 1974, 1758,
However, as shown in Table 1, L-carnitine was detected.
Claims (1)
−β−ヒドロキシ酪酸に変換せしめるに際し、γ−ハロ
ゲン化クロトン酸を、光学活性なγ−ハロゲン化−β−
ヒドロキシ酪酸に変換せしめる能力を有する微生物を水
性媒体中で作用させる事を特徴とする、光学活性なγ−
ハロゲン化−β−ヒドロキシ酪酸の製法。When converting γ-halogenated crotonic acid into optically active γ-halogenated β-hydroxybutyric acid, γ-halogenated crotonic acid is converted into optically active γ-halogenated β-hydroxybutyric acid.
An optically active γ-
Method for producing halogenated-β-hydroxybutyric acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8454885A JPS61242585A (en) | 1985-04-22 | 1985-04-22 | Production of gamma-halogenated-beta-hydroxybutyric acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8454885A JPS61242585A (en) | 1985-04-22 | 1985-04-22 | Production of gamma-halogenated-beta-hydroxybutyric acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS61242585A true JPS61242585A (en) | 1986-10-28 |
Family
ID=13833697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8454885A Pending JPS61242585A (en) | 1985-04-22 | 1985-04-22 | Production of gamma-halogenated-beta-hydroxybutyric acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61242585A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005005648A1 (en) * | 2003-07-11 | 2005-01-20 | Mitsubishi Pharma Corporation | Novel process for producing optically active carboxylic acid |
-
1985
- 1985-04-22 JP JP8454885A patent/JPS61242585A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005005648A1 (en) * | 2003-07-11 | 2005-01-20 | Mitsubishi Pharma Corporation | Novel process for producing optically active carboxylic acid |
JPWO2005005648A1 (en) * | 2003-07-11 | 2007-09-20 | 三菱ウェルファーマ株式会社 | Process for producing novel optically active carboxylic acids |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4080259A (en) | Process of preparing L and D α-amino acids by enzyme treatment of DL-α-amino acid amide | |
EP0449648A2 (en) | Process for producing R(-)-mandelic acid and derivatives thereof | |
JP2840722B2 (en) | Method for producing 4-halo-3-hydroxybutyronitrile | |
US4857469A (en) | Process for preparing optically active mercapto compound | |
JPS61242585A (en) | Production of gamma-halogenated-beta-hydroxybutyric acid | |
JPH022589B2 (en) | ||
JP3030916B2 (en) | Method for producing β-glucooligosaccharide | |
US5134073A (en) | Microbiologically produced n-acetyl-2,3-didehydroleucine acylase | |
US5212069A (en) | Method of using N-acetyl-2,3-Didehydroleucine acylase for the preparation of D- or L-tryptophyl glycine, D- or L-tryptophyl-D-methionine or L-tryptophyl-D-cysteine | |
JPS6319158B2 (en) | ||
JP2840723B2 (en) | Method for producing 4-halo-3-hydroxybutyronitrile | |
US5322782A (en) | Method of synthesizing optically active β-halolactic acid | |
JPS61242588A (en) | Production of beta-hydroxynitrile | |
JPH0231684A (en) | Production of optically active 1,3-butanediol | |
JP2946055B2 (en) | Method for producing optically active (S)-(+)-3-halo-1,2-propanediol | |
US4877734A (en) | Microbiologically produced α-acetylamino cinnamic acid acylase, method of its production and its use | |
JP2674078B2 (en) | Process for producing D-α-amino acid | |
JPH01277499A (en) | Production of l-alpha-amino acid | |
GB1577087A (en) | Enzyme preparation having l-amino acyl amidase activity | |
JP3917723B2 (en) | Lactone hydrolase and process for producing the same | |
JP2674076B2 (en) | Method for producing D-α-amino acid | |
JPH03183499A (en) | Production of optically active 3-hydroxybutyric acid | |
JPH04152895A (en) | Production of optically active 1,3-butanediol | |
JPH04341195A (en) | Production of optically active mandelic acid | |
JPS61242587A (en) | Production of beta-hydroxy compound |